As we already discuss in the introduction to this paper, DeMeo et al. [12] report that COPD progression in α-1-antitrypsin deficiency associated with IL-10 polymorphisms and α-1 antitrypsin replacement therapy increases circulating IL-10 in these individuals. This evidence concerns the gene IL10 and chronic obstructive pulmonary disease.